NAFLD/NASH in Children

Fatty Liver Disease: NASH and Related Disorders

Volumn , Issue , 2007, Pages 229-240

  Lavine, Joel E ^a   Schwimmer, Jeffrey B ^b  

^a UCSD MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Fibrosis; Hepatitis C; Nonalcoholic steatohepatitis (NASH); Vitamin E; Wilson's disease

Indexed keywords

EID: 33744918166     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987438.ch19     Document Type: Chapter

References (33)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
2. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78: 374-7.
3. Kinugasa A, Tsunamoto K, Furukawa N et al. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3: 408-14.
4. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127: 700-4.
5. Schwimmer JB, Deustch R, Behling C et al. Obesity, insulin resistance, and other clinicopathological correlations of pediatric non-alcoholic fatty liver disease. J Pediatr 2003; 143: 500-6.
6. Rashid M, Roberts EA. Non-alcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 4853.
7. Manton ND, Lipsett J, Moore DJ et al. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 2000; 173: 476-9.
8. Vajro PFA, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239-41.
9. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002; 97: 2460-2.
10. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander- Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
11. Schwimmer JB, Behling C, Newbury R et al. The histological features of pediatric non-alcoholic fatty liver disease (NAFLD) [Abstract]. Hepatology 2002; 36: 412A.
12. Ogden CL FK, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents. J Am Med Assoc 2002; 288: 1728-32.
13. Franzese A, Vajro P, Argenziano A et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-32.
14. Tominaga K, Kurata JH, Chen YH et al. Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-9.
15. Fishbein MH, Miner M, Mogren C, Chalckson J. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr 2003; 36: 54-61.
16. Bergomi A, Lughetti L, Corciulo N. Italian multicenter study on liver damage in pediatric obesity [Abstract]. Int J Obes Relat Metab Disord 1998; 22: S22.
17. Mofrad P, Contos MJ, Haque M et al. Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-92.
18. Cook JS. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 1993; 77: 725-30.
19. Bloch CA, Clemens P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987; 110: 481-7.
20. Ellis KJ. Body composition of a young, multiethnic, male population. Am J Clin Nutr 1997; 1997: 1323-31.
21. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003; 88: 1417-27.
22. Haque M, Sanyal A. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2002; 16: 709-31.
23. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
24. Day CP, James OF. Steatohepatitis: a tale of two 'hits'?. Gastroenterology 1998; 114: 842-5.
25. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-5.
26. Fishbein MH, Stevens WR. Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol 2001; 31: 806-9.
27. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
28. Vajro PFA, Vlaerio G, Iannucci MP, Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 2000; 136: 739-43.
29. Lavine JE. Vitamin E treatment of non-alcoholic steato- hepatitis in children: a pilot study. J Pediatr 2000; 136: 734-8.
30. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-β1 level and efficacy of a-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15: 1667-72.
31. Marchesini G, Brizi M, Bianchi G et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358: 893-4.
32. Schwimmer JB, Middleton M, Deutsch R, Lavine JE. Metformin as a treatment for non-diabetic NASH. J Pediatr Gastroenterol Nutr 2003; 37: 342.
33. Menon KVN, Angulo P, Lindor KD. Severe cholestatic hepatitis from troglitazone in a patient with non-alcoholic steatohepatitis and diabetes mellitus. Am J Gastroenterol 2001; 96: 1631-4.